Cargando…
Prognostic Value of Plasma Pentraxin-3 Levels in Patients with Stable Coronary Artery Disease after Drug-Eluting Stent Implantation
Pentraxin-3 (PTX3) is an inflammatory marker thought to be more specific to cardiovascular inflammation than C-reactive protein (CRP). Our aim was to assess the prognostic value of PTX3 in patients with stable coronary artery disease (CAD) after drug eluting stent (DES) implantation. Plasma PTX3 lev...
Autores principales: | Haibo, Liu, Xiaofang, Guo, Chunming, Wang, Jie, Yuan, Guozhong, Chen, Limei, Zhang, Yong, Cao, Yu, Fang, Yingchun, Bao, Wangjun, Yu, Junbo, Ge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265374/ https://www.ncbi.nlm.nih.gov/pubmed/25538378 http://dx.doi.org/10.1155/2014/963096 |
Ejemplares similares
-
Pentraxin-3 Predicts Long-Term Cardiac Events in Patients with Chronic Heart Failure
por: Liu, Haibo, et al.
Publicado: (2015) -
Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019) -
Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
por: Sharma, Raghav, et al.
Publicado: (2022) -
Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010) -
Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease
por: Gabbasov, Zufar, et al.
Publicado: (2018)